Merck Announces First-Quarter 2024 Financial Results

Go back to Merck Announces First-Quarter 2024 Financial Results

Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates

April 25, 2024 6:47 AM EDT

Merck (NYSE: MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked its outlook for the fiscal year 2024.

For Q1 2024, Merck reported earnings per share (EPS) at $2.07, surpassing analyst expectations of $1.93. The companys revenue for the quarter was $15.8 billion,... More